Acetylsalicylic acid, 99%, Thermo Scientific Chemicals

Acetylsalicylic acid, aspirin, CAS# 50-78-2, is a non-steroidal anti-inflammatory that is used widely as an analgesic and antipyretic.

Catalog Number	Quantity	Packaging
158180500	50 g	Plastic bottle

This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.

Catalog number 158180500

Price (EUR)

Quantity:

Packaging:

Plastic bottle

Request bulk or custom format

Chemical Identifiers

CAS50-78-2

IUPAC Name2-(acetyloxy)benzoic acid

Molecular FormulaC9H8O4

InChI KeyBSYNRYMUTXBXSQ-UHFFFAOYSA-N

SMILESCC(=O)OC1=CC=CC=C1C(O)=O

Specifications

Sulfated ash=<0.1 %

Melting point133°C to 139°C

Titration with NaOH98.5 to 101.5 % (On dried substance)

Loss on drying=<0.5 % (1 g) (vacuum, over P2O5, room temp)

Infrared spectrumConforms

This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the legacy brand. The original Acros Organics product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

General description
• Acetylsalicylic acid is a common non-steroidal anti-inflammatory (NSAID) and
• Acetylsalicylic acid works by inhibiting cyclooxygenases, reducing prostaglandin production and the release of pyrogens

Applications
• Acetylsalicylic acid is useful for research on fever, postoperative pain, blood clots, and inflammation
• Acetylsalicylic acid may also be used in the study of cancer prevention
• Intended for research use only

Literature references

Levine, G.N.; Bates, E.R.; Bittl, J.A.; Brindis, R.G.; Fihn, S.D.; Fleisher, L.A.; Granger, C.B.; Lange, R.A.; Mack, M.J.; Mauri, L.; Mehran, R.; Mukherjee, D.; Newby, L.K.; O'Gara, P.T.; Sabatine, M.S.; Smith, P.K.; Smith, S.C. Jr. 2016, ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016, 68(10), 1082-115.

Hoffman, M.K.; Goudar, S.S.; Kodkany, B.S.; Metgud, M.; Somannavar, M.; Okitawutshu, J.; Lokangaka, A.; Tshefu, A.; Bose, C.L.; Mwapule, A.; Mwenechanya, M.; Chomba, E.; Carlo, W.A.; Chicuy, J.; Figueroa, L.; Garces, A.; Krebs, N.F.; Jessani, S.; Zehra F.; Saleem, S.; Goldenberg, R.L.; Kurhe, K.; Das, P.; Patel, A.; Hibberd, P.L.; Achieng, E.; Nyongesa, P.; Esamai, F.; Liechty, E.A.; Goco, N.; Hemingway-Foday, J.; Moore, J.; Nolen, T.L.; McClure, E.M.; Koso-Thomas, M.; Miodovnik, M.; Silver, R.; Derman, R.J. ASPIRIN Study Group. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020, 25, 395(10220), 285-293.

RUO – Research Use Only

General References:

Levine, G.N.; Bates, E.R.; Bittl, J.A.; Brindis, R.G.; Fihn, S.D.; Fleisher, L.A.; Granger, C.B.; Lange, R.A.; Mack, M.J.; Mauri, L.; Mehran, R.; Mukherjee, D.; Newby, L.K.; O'Gara, P.T.; Sabatine, M.S.; Smith, P.K.; Smith, S.C. Jr. 2016, ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016, 68(10), 1082-115.
Hoffman, M.K.; Goudar, S.S.; Kodkany, B.S.; Metgud, M.; Somannavar, M.; Okitawutshu, J.; Lokangaka, A.; Tshefu, A.; Bose, C.L.; Mwapule, A.; Mwenechanya, M.; Chomba, E.; Carlo, W.A.; Chicuy, J.; Figueroa, L.; Garces, A.; Krebs, N.F.; Jessani, S.; Zehra F.; Saleem, S.; Goldenberg, R.L.; Kurhe, K.; Das, P.; Patel, A.; Hibberd, P.L.; Achieng, E.; Nyongesa, P.; Esamai, F.; Liechty, E.A.; Goco, N.; Hemingway-Foday, J.; Moore, J.; Nolen, T.L.; McClure, E.M.; Koso-Thomas, M.; Miodovnik, M.; Silver, R.; Derman, R.J. ASPIRIN Study Group. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020, 25, 395(10220), 285-293.